Medical and biological research using human biological samples (HBS) is conducted to further knowledge that contributes to human health and quality of life. Such samples are important for studies which aim to elucidate the mechanisms of human disease and discover new treatments.
-
Sanofi believes that research using HBS is critical to the development of safe and efficacious medicines and vaccines.
-
Sanofi is committed to collecting, storing and using HBS consistent with high ethical standards which protect the dignity and identity of human donors. Biomedical research using HBS must always be carried out with respect for human rights. Informed consent must be freely-given.
-
The HBS must be collected without inducement.
-
The collection and use of HBS and/or associated data for research should never adversely affect patient care.
-
Sanofi will seek to ensure that in collecting a sample, the physical risks to the donor are minimized.
-
We will also protect the privacy and confidentiality of any data derived from the sample. In addition, the risks related to privacy and confidentiality of donors’ families, and/or identifiable populations or groups will be minimized to the greatest extent possible.
-
As with all aspects of our research, Sanofi will take into account any actions needed to avoid discrimination against, or stigmatization of, a person, family or group when collecting, using and storing biological samples.
Notwithstanding the above Sanofi conduct all studies in accordance with relevant national and local regulations and laws.
Principles on Collection, Storage and Use of Human Biological Samples for Research approved by Sanofi Bioethics Committee (first approval in June 2015 – last review in June 2018)